Healthcare
Panamera Holdings Corporation(PHCI)
Live Price
Offline$2.55
+0.00% today
1Y Change
-62.50%
Window
Jun 23, 2025 โ Jun 15, 2026
- Market Cap
- $370.00M
- Revenue Growth
- +1129.1%
- EPS Growth
- +96.9%
- Dividend Yield
- 0.0%
Coverage: 253 bars ยท Jun 23, 2025 โ Jun 15, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Panamera Holdings Corporation (PHCI) is a Healthcare stock with a market cap of $370.00M and listed on OTC. The stock last traded around $2.55 and down 62.5% across the available one-year price window (Jun 23, 2025 โ Jun 15, 2026). Baseline metrics include revenue growth of +1129.1%, EPS growth of +96.9%, a dividend yield of 0.0%. What stands out right now is revenue +1129.1%, EPS +96.9%, free cash flow -418.5% with operating margin -51672.8% and ROIC 3783.0%. Valuation already assumes a fairly strong business story at price/sales 1239.2. Overall, the current profile looks closer to a higher-growth but lower-margin setup than a generic broad-market placeholder. Stock Foundry combines PHCI price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Sector Context
How this name stacks up against nearby peers on first-pass metrics.
Revenue Growth
Above sector median
+1129.1% vs +7.6% peer median
Operating Margin
Below sector median
-51672.8% vs +19.4% peer median
What Changed This Quarter
Latest report context and the signals most likely to have changed the story.
Latest report is on the board
2024 was reported on Jan 31, 2024, but the surprise data is still limited.
The operating story is still moving forward
Revenue is running at +1129.1% and EPS at +96.9%, with operating margin around -51672.8%.
Earnings Reaction Memory
How the stock has tended to move after recent reports.
Across the last 3 reported quarters, the stock averaged +37.3% over the next 5 trading days and finished higher after 3 of those reports.
View quarter-by-quarter reaction table
| Quarter | EPS ฮ | 1D | 5D | 20D |
|---|---|---|---|---|
2024 Jan 31, 2024 | โ | +0.0% | +37.3% | +37.7% |
2023 Oct 31, 2023 | โ | +0.0% | +37.3% | +37.7% |
2023 Apr 30, 2023 | โ | +0.0% | +37.3% | +37.7% |
Benchmark Comparison
Normalized Performance vs SPY
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
PHCI
โ
Normalized return
SPY
โ
S&P 500
Excess Return
โ
Relative to SPY
PHCI Max Drawdown
-85.00%
Trailing 1Y
SPY Max Drawdown
โ
Trailing 1Y
Calendar-Year Returns
Uses the longest available daily history for PHCI and SPY.
Company Overview
Panamera Holdings Corporation
Other OTC
Panamera Holdings Corporation does not have significant operations. Previously, the company was engaged in the provision of management and consulting services to healthcare organizations. It intends to seek new opportunities or business arrangements primarily in the environmental services industry, emerging innovative technologies, and individual health choices led by innovation and integration. The company was formerly known as Panamera Healthcare Corporation and changed its name to Panamera Holdings Corporation in October 2021. Panamera Holdings Corporation was incorporated in 2014 and is based in Houston, Texas.
- Leadership
- T. Benjamin Jennings
- IPO Date
- Apr 21, 2021
- Employees
- 3
- Street Address
- 4180 Orchard Hill Drive
- Mailing
- Edmond, OK, 77002
- Region
- Edmond, OK, US
- Reporting Currency
- USD
- Investor Line
- 480 699 0009
- Last Updated
- May 3, 2026
Key Fundamentals
Valuation, growth, profitability, and balance sheet signals.
Valuation
- P/E
- โ
- EV/EBITDA
- โ
- Price/Sales
- 1239.2
- Price/Book
- โ
Growth
- Revenue
- +1129.1%
- EPS
- +96.9%
- Free Cash Flow
- -418.5%
Profitability
- Gross Margin
- 34.4%
- Operating Margin
- -51672.8%
- Net Margin
- -51700.6%
- ROE
- 8214.1%
- ROIC
- 3783.0%
Balance Sheet
- Debt/Equity
- โ
- Current Ratio
- 0.02
Earnings Reports
Latest News
Official Releases
Company announcements and filings-style updates.
Next Step
Keep the research moving
After the overview, the strongest next step is usually chart context or a tighter compare set.